Clinical trial
Pemetrexed in Patients With Soft Tissue Sarcoma
NCT00427466 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00427466 |
|---|---|
| Title | Pemetrexed in Patients With Soft Tissue Sarcoma |
| Official title | Multicenter Phase II Study With Pemetrexed in Patients With Pre-Treated Metastatic Soft Tissue Sarcomas |
| Lead sponsor | University Hospital Tuebingen, Other |
| Collaborators | Arbeitsgemeinschaft fur Internistische Onkologie German Sarcoma Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | Pemetrexed |
| Enrollment | 54 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jan 29, 2007 |
| Last update posted | Feb 16, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: